Transplantation of a Bacterial Consortium Ameliorates Trinitrobenzenesulfonic Acid-Induced Colitis and Intestinal Dysbiosis in Rats

References

• Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126, 1504 – 1517 (2004).
   PubMed Web of Science ®Google Scholar
• Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427 – 434 (2007).
   PubMed Web of Science ®Google Scholar
• Machiels K, Joossens M, Sabino J et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63, 1275 – 1283 (2014).
   PubMed Web of Science ®Google Scholar
• Gevers D, Kugathasan S, Denson LA et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382 – 392 (2014).
   PubMed Web of Science ®Google Scholar
• Jostins L, Ripke S, Weersma RK et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119 – 124 (2012).
   PubMed Web of Science ®Google Scholar
• Talley NJ, Abreu MT, Achkar JP et al. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am. J. Gastroenterol. 106 (Suppl. 1 ), S2 – S25 (2011).
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Lammers KM et al. Antibiotics and probiotics in treatment of inflammatory bowel disease. World J. Gastroenterol. 12, 3306 – 3313 (2006).
   PubMed Web of Science ®Google Scholar
• Cammarota G, Ianiro G, Gasbarrini A. Fecal microbiota transplantation for the treatment of clostridium difficile infection: a systematic review. J. Clin. Gastroenterol. 48, 693 – 702 (2014).
   PubMed Web of Science ®Google Scholar
• Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat. Rev. Gastroenterol. Hepatol. 9, 88 – 96 (2012).
   PubMed Web of Science ®Google Scholar
• van Nood E, Vrieze A, Nieuwdorp M et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407 – 415 (2013).
   PubMed Web of Science ®Google Scholar
• Weingarden AR, Chen C, Bobr A et al. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am. J. Physiol. Gastrointest. Liver. Physiol. 306, G310 – G319 (2014).
   PubMed Web of Science ®Google Scholar
• Kunde S, Pham A, Bonczyk S et al. Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis. J. Pediatr. Gastr. Nutr. 56, 597 – 601 (2013).
   PubMed Web of Science ®Google Scholar
• Kao D, Hotte N, Gillevet P, Madsen K. Fecal microbiota transplantation inducing remission in crohn's colitis and the associated changes in fecal microbial profile. J. Clin. Gastroenterol. 48, 625 – 628 (2014).
   PubMed Web of Science ®Google Scholar
• Shanahan F, Quigley EM. Manipulation of the microbiota for treatment of IBS and IBD – challenges and controversies. Gastroenterology 146, 1554 – 1563 (2014).
   PubMed Web of Science ®Google Scholar
• Udayappan SD, Hartstra AV, Dallinga-Thie GM, Nieuwdorp M. Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and Type 2 diabetes mellitus. Clini. Exp. Immunol. 177, 24 – 29 (2014).
   PubMed Web of Science ®Google Scholar
• Smits LP, Bouter KE, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 145, 946 – 953 (2013).
   PubMed Web of Science ®Google Scholar
• Moayyedi P, Surette MG, Kim PT et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149, 102 – 109 (2015).
   PubMed Web of Science ®Google Scholar
• Wei Y, Zhu W, Gong J et al. Fecal microbiota transplantation improves the quality of life in patients with inflammatory bowel disease. Gastroenterol. Res. Pract. 2015, 517 – 597 (2015).
   Web of Science ®Google Scholar
• Kump PK, Grochenig HP, Lackner S et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm. Bowel Dis. 19, 2155 – 2165 (2013).
   PubMed Web of Science ®Google Scholar
• Angelberger S, Reinisch W, Makristathis A et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am. J. Gastroenterol. 108, 1620 – 1630 (2013).
   PubMed Web of Science ®Google Scholar
• Zipursky JS, Sidorsky TI, Freedman CA, Sidorsky MN, Kirkland KB. Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin. Infect. Dis. 55, 1652 – 1658 (2012).
   PubMed Web of Science ®Google Scholar
• Lawley TD, Clare S, Walker AW et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing clostridium difficile disease in mice. PLoS Pathog. 8, e1002995 (2012).
   PubMed Web of Science ®Google Scholar
• Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1, 1156 – 1160 (1989).
   PubMed Web of Science ®Google Scholar
• Petrof EO, Gloor GB, Vanner SJ et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘repoopulating’ the gut. Microbiome 1, 3 (2013).
   PubMed Web of Science ®Google Scholar
• Petrof EO, Khoruts A. From stool transplants to next-generation microbiota therapeutics. Gastroenterology 146, 1573 – 1582 (2014).
   PubMed Web of Science ®Google Scholar
• Hart AL, Hendy P. The microbiome in inflammatory bowel disease and its modulation as a therapeutic manoeuvre. Proc. Nutr. Soci. 73, 452 – 456 (2014).
   PubMed Web of Science ®Google Scholar
• Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin. Infect. Dis. 60 (Suppl. 2 ), S108 – S121 (2015).
   PubMed Web of Science ®Google Scholar
• Aroniadis OC, Brandt LJ. Intestinal microbiota and the efficacy of fecal microbiota transplantation in gastrointestinal disease. Gastroenterol. Hepatol. 10 (4 ), 230 – 237 (2014).
   Google Scholar
• Jonkers D, Penders J, Masclee A, Pierik M. Probiotics in the management of inflammatory bowel disease. A systematic review of intervention studies in adult patients. Drugs 72 (6 ), 803 – 823 (2012).
   PubMed Web of Science ®Google Scholar
• Li M, Liang P, Li Z et al. Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis. Front. Microbiol. 6, 692 (2015).
   PubMed Web of Science ®Google Scholar
• Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96, 795 – 803 (1989).
   PubMed Web of Science ®Google Scholar
• Bobin-Dubigeon C, Collin X, Grimaud N, Robert JM, Le Baut G, Petit JY. Effects of tumour necrosis factor-alpha synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis. Eur. J. Pharmacol. 431, 103 – 110 (2001).
   PubMed Web of Science ®Google Scholar
• Hamamoto N, Maemura K, Hirata I, Murano M, Sasaki S, Katsu K. Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1)). Clin. Exp. Immunol. 117, 462 – 468 (1999).
   PubMed Web of Science ®Google Scholar
• Joossens M, Huys G, Van Steen K et al. High-throughput method for comparative analysis of denaturing gradient gel electrophoresis profiles from human fecal samples reveals significant increases in two bifidobacterial species after inulin-type prebiotic intake. FEMS Microbiol. Ecol. 75, 343 – 349 (2011).
   PubMed Web of Science ®Google Scholar
• Eeckhaut V, Machiels K, Perrier C et al. Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut 62, 1745 – 1752 (2013).
   PubMed Web of Science ®Google Scholar
• Shen J, Zhang B, Wei H et al. Assessment of the modulating effects of fructo-oligosaccarides on fecal microbiota using human flora-associated piglets. Arch. Microbiol. 192, 959 – 968 (2010).
   PubMed Web of Science ®Google Scholar
• Mitsuoka T. Intestinal Bacteria and Health: an Introductory Narrative. Harcourt Brace Jovanovich Japan, Tokyo, Japan (1978).
   Google Scholar
• Tong M, Li X, Wegener Parfrey L et al. A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. PLoS ONE 8, e80702 (2013).
   PubMed Web of Science ®Google Scholar
• He Q, Wang L, Wang F et al. Microbial fingerprinting detects intestinal microbiota dysbiosis in zebrafish models with chemically-induced enterocolitis. BMC Microbiol. 13, 289 (2013).
   PubMed Web of Science ®Google Scholar
• Gkouskou KK, Deligianni C, Tsatsanis C, Eliopoulos AG. The gut microbiota in mouse models of inflammatory bowel disease. Front. Cell Infect. Microbiol. 4, 28 (2014).
   PubMed Web of Science ®Google Scholar
• Suskind DL, Brittnacher MJ, Wahbeh G et al. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active crohn's disease. Inflamm. Bowel Dis. 21, 556 – 563 (2015).
   PubMed Web of Science ®Google Scholar
• Huda-Faujan N, Abdulamir AS, Fatimah AB et al. The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem. J. 4, 53 – 58 (2010).
   PubMedGoogle Scholar
• Kelly CJ, Zheng L, Campbell EL et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17, 662 – 671 (2015).
   PubMed Web of Science ®Google Scholar
• Bloom SM, Bijanki VN, Nava GM et al. Commensal bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 9, 390 – 403 (2011).
   PubMed Web of Science ®Google Scholar
• Lai CC, Cheng A, Huang YT et al. Escherichia fergusonii bacteremia in a diabetic patient with pancreatic cancer. J. Clin. Microbiol. 49, 4001 – 4002 (2011).
   PubMed Web of Science ®Google Scholar
• Machiels K, Sabino J, Vandermosten L et al. Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC. Gut doi:10.1136/gutjnl-2015-309398 (2015 ) ( Epub ahead of print).
   Web of Science ®Google Scholar
• Hashash JG, Chintamaneni P, Ramos Rivers CM et al. Patterns of antibiotic exposure and clinical disease activity in inflammatory bowel disease: a 4-year prospective study. Inflamm. Bowel Dis. 21 (11 ), 2576 – 2582 (2015).
   PubMed Web of Science ®Google Scholar
• Dieleman LA, Goerres MS, Arends A et al. Lactobacillus GG prevents recurrence of colitis in HLA-b27 transgenic rats after antibiotic treatment. Gut 52, 370 – 376 (2003).
   PubMed Web of Science ®Google Scholar
• Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156, 3216 – 3223 (2010).
   PubMed Web of Science ®Google Scholar
• Chang JY, Antonopoulos DA, Kalra A et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis. 197, 435 – 438 (2008).
   PubMed Web of Science ®Google Scholar
• Binder HJ. Role of colonic short-chain fatty acid transport in diarrhea. Annu. Rev. Physiol. 72, 297 – 313 (2010).
   PubMed Web of Science ®Google Scholar
• Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl Acad. Sci. USA 108 (Suppl. 1 ), 4554 – 4561 (2011).
   PubMed Web of Science ®Google Scholar
• Atarashi K, Tanoue T, Oshima K et al. Treg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature 500, 232 – 236 (2013).
   PubMed Web of Science ®Google Scholar